- Home
- TXG
TXG
10x Genomics Inc.
as 11-15-2024 4:00pm EST
| Founded: | 2012 | Country: | United States |
| Employees: | N/A | City: | PLEASANTON |
| Market Cap: | N/A | IPO Year: | 2019 |
| Target Price: | $25.14 | AVG Volume (30 days): | 2.0M |
| Analyst Decision: | Buy | Number of Analysts: | 16 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.53 | EPS Growth: | N/A |
| 52 Week Low/High: | $13.30 - $57.90 | Next Earning Date: | 10-29-2024 |
| Revenue: | $629,743,000 | Revenue Growth: | 6.56% |
| Revenue Growth (this year): | -2.19% | Revenue Growth (next year): | 6.14% |
Stock Insider Trading Activity of 10x Genomics Inc. (TXG)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Saxonov Serge | TXG | Chief Executive Officer | Aug 22 '24 | Sell | $22.53 | 6,749 | $152,052.95 | 882,467 | |
| Hindson Benjamin J. | TXG | See Remarks | Aug 22 '24 | Sell | $22.53 | 4,351 | $98,026.72 | 345,704 | |
| McAnear Justin J. | TXG | N/A | Aug 22 '24 | Sell | $22.53 | 2,961 | $66,710.44 | 143,242 |
Latest 10x Genomics Inc. News
TXG Breaking Stock News: Dive into TXG Ticker-Specific Updates for Smart Investing
PR Newswire
10 days ago
10x Genomics to Present at the Wolfe Research 2024 Healthcare Conference
Simply Wall St.
16 days ago
Earnings Update: 10x Genomics, Inc. (NASDAQ:TXG) Just Reported And Analysts Are Trimming Their Forecasts
PR Newswire
17 days ago
TechBio Startup Cure51 Selects 10x Genomics Visium HD for New Drug Discovery Initiative
MT Newswires
18 days ago
UBS Adjusts Price Target on 10x Genomics to $20 From $25, Maintains Neutral Rating
Thomson Reuters StreetEvents
18 days ago
Q3 2024 10X Genomics Inc Earnings Call
GuruFocus.com
18 days ago
10x Genomics Inc (TXG) Q3 2024 Earnings Call Highlights: Navigating Challenges with Strategic ...
Zacks
19 days ago
10x Genomics (TXG) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
Zacks
19 days ago
10x Genomics (TXG) Reports Q3 Loss, Tops Revenue Estimates
Compare TXG vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "TXG 10x Genomics Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.